RPG LIFE SCIENCES
|
RPG LIFE SCIENCES Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 110.80 | 53.01 | 40.90 | 31.13 | 24.19 |
| CEPS(Rs) | 123.76 | 63.33 | 50.27 | 40.60 | 34.15 |
| DPS(Rs) | 24.00 | 16.00 | 12.00 | 9.60 | 7.20 |
| Book NAV/Share(Rs) | 320.80 | 226.67 | 186.00 | 154.66 | 130.88 |
| Tax Rate(%) | 21.32 | 25.61 | 26.22 | 29.64 | 25.35 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 22.69 | 20.70 | 18.66 | 18.18 | 16.87 |
| EBIT Margin(%) | 33.46 | 19.12 | 16.73 | 15.55 | 13.20 |
| Pre Tax Margin(%) | 33.24 | 18.89 | 16.53 | 15.26 | 12.77 |
| PAT Margin (%) | 26.15 | 14.05 | 12.19 | 10.74 | 9.53 |
| Cash Profit Margin (%) | 29.21 | 16.79 | 14.99 | 14.00 | 13.46 |
| Performance Ratios | |||||
| ROA(%) | 31.35 | 18.82 | 17.71 | 15.89 | 14.00 |
| ROE(%) | 40.48 | 25.69 | 24.01 | 21.80 | 20.36 |
| ROCE(%) | 51.79 | 34.96 | 32.92 | 31.46 | 27.27 |
| Asset Turnover(x) | 1.20 | 1.34 | 1.45 | 1.48 | 1.47 |
| Sales/Fixed Asset(x) | 2.82 | 2.83 | 2.73 | 2.61 | 2.37 |
| Working Capital/Sales(x) | 2.03 | 3.73 | 3.44 | 3.78 | 4.36 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.36 | 0.35 | 0.37 | 0.38 | 0.42 |
| Receivable days | 35.40 | 25.32 | 23.17 | 34.41 | 52.52 |
| Inventory Days | 50.53 | 57.35 | 58.57 | 53.79 | 45.64 |
| Payable days | 139.59 | 147.58 | 128.38 | 132.94 | 138.23 |
| Valuation Parameters | |||||
| PER(x) | 20.56 | 28.87 | 17.01 | 17.98 | 16.00 |
| PCE(x) | 18.40 | 24.16 | 13.84 | 13.78 | 11.34 |
| Price/Book(x) | 7.10 | 6.75 | 3.74 | 3.62 | 2.96 |
| Yield(%) | 1.05 | 1.05 | 1.72 | 1.72 | 1.86 |
| EV/Net Sales(x) | 5.55 | 4.29 | 2.13 | 1.94 | 1.54 |
| EV/Core EBITDA(x) | 20.93 | 18.29 | 10.10 | 9.48 | 8.36 |
| EV/EBIT(x) | 15.47 | 20.91 | 11.78 | 11.48 | 10.85 |
| EV/CE(x) | 6.84 | 6.65 | 3.56 | 2.48 | 1.98 |
| M Cap / Sales | 5.76 | 4.35 | 2.24 | 2.10 | 1.65 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 12.26 | 13.50 | 16.51 | 13.11 | 3.61 |
| Core EBITDA Growth(%) | 27.10 | 25.87 | 20.05 | 25.61 | 17.98 |
| EBIT Growth(%) | 96.57 | 28.49 | 24.47 | 34.69 | 41.21 |
| PAT Growth(%) | 109.03 | 29.60 | 31.39 | 28.70 | 37.88 |
| EPS Growth(%) | 109.03 | 29.60 | 31.39 | 28.70 | 37.88 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | 0.01 |
| Current Ratio(x) | 3.88 | 2.28 | 2.57 | 2.58 | 2.21 |
| Quick Ratio(x) | 3.11 | 1.50 | 1.64 | 1.55 | 1.47 |
| Interest Cover(x) | 147.47 | 82.83 | 80.72 | 52.89 | 30.93 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of RPG LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| RPG LIFE SCIENCES | ₹3,886.7 Cr | 3.3% | -5% | 9.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹394,187.0 Cr | 0.6% | -2.4% | -7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,282.0 Cr | -0.3% | -7.6% | 23% | Stock Analytics | |
| CIPLA | ₹128,619.0 Cr | 1.8% | 8.1% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,712.0 Cr | 0.9% | 3.7% | 8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,577.0 Cr | 1% | 2.4% | -9.6% | Stock Analytics | |
RPG LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| RPG LIFE SCIENCES | 3.3% |
-5% |
9.8% |
| SENSEX | 0.9% |
-1.1% |
0.6% |
You may also like the below Video Courses
